(Q46378358)

21 December 2017

title

Effects of itraconazole or grapefruit juice on the pharmacokinetics of telithromycin (English)

1 reference

21 December 2017

1 reference

Jun Shi

1

1 reference

21 December 2017

Guy Montay

series ordinal

2

1 reference

21 December 2017

Bruno Leroy

series ordinal

3

1 reference

21 December 2017

Vijay O Bhargava

series ordinal

4

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

21 December 2017

published in

Pharmacotherapy

1 reference

21 December 2017

volume

25

1 reference

21 December 2017

issue

1

1 reference

21 December 2017

page(s)

42-51

1 reference

21 December 2017

Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999.

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.42.55621

Ketolides-telithromycin, an example of a new class of antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.42.55621

The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.42.55621

Pharmacokinetics of the new ketolide telithromycin (HMR 3647) administered in ascending single and multiple doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.42.55621

Pharmacokinetics of the ketolide telithromycin after single and repeated doses in patients with hepatic impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.42.55621

Pharmacokinetics and safety of the ketolide telithromycin in patients with renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.42.55621

Cytochrome P-450 3A4: regulation and role in drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.42.55621

Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.42.55621

Rate-corrected QT interval: techniques and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.42.55621

Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.42.55621

The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine*

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.42.55621

Drug interactions with grapefruit juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.42.55621

Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.42.55621

Grapefruit juice activates P-glycoprotein-mediated drug transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.42.55621

The effects of grapefruit juice on the pharmacokinetics of erythromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.42.55621

Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.42.55621

10.1592/PHCO.25.1.42.55621

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017